Measurements

Inventiva Confirms Safety of Liver Disease Drug in Clinical Trial Measuring Cardiac Electrical Activity

By John V. Lyons

MT 2021 press wires

All the news of INVENTIVA

Analyst recommendations on INVENTIVA
Sales 2021 5.07 M
5.72 million
5.72 million
Net income 2021 -51.6 million
-58.3 million
-58.3 million
Net cash position 2021 47.3 million
53.4 million
53.4 million
PER 2021 ratio -10.0x
Yield 2021 –
Capitalization 493 million
556 million
556 million
VE / Sales 2021 87.9x
VE / Sales 2022 12.0x
Number of employees 100
Free float 78.3%

Duration :

Period:

Inventiva Technical Analysis Chart | MarketScreener

Trends in technical analysis INVENTIVA

Short term Mid Road Long term
Tendencies Bearish Bullish Neutral

Evolution of the income statement

To sell

To buy
Average consensus TO BUY
Number of analysts 7
Last closing price

€ 12.06

Average price target

€ 27.23

Spread / Average target 126%


Source link

Related posts:

  1. Continuous emission measurement | Hydrocarbon engineering
  2. EBU Technology & Innovation – Measuring and reducing the carbon footprint of arte.tv
  3. Remote-controlled ocean drones observe atmospheric cold pools
  4. The market for physico-chemical property measurements will experience exceptional growth during the period 2021-2026
John V. Lyons
You might also like More from author

Comments are closed.